1
|
International Journal
Joshi Shreerang V.; Joshi, Maithili; Danave, Ameya; Kharkar, Prashant S. Chemistry of iodinated contrast media: A Minireview. Mini-Rev. Org. Chem. 2021, 18 (Published online) [Clarivate Analytics Impact Factor (2019): 1.824].
JAN 2021
|
|
2
|
International Journal
Telange, Darshan R.; Jain, Shirish P.; Pethe, Anil M.; Kharkar, Prashant S.; Rarokar, Nilesh R. Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid. Int. J. Biol. Macromol. 2021, 171, 288-307. [Clarivate Analytics Impact Factor (2019): 5.162].
FEB 2021
|
|
3
|
International Journal
Shinde, Kailas W.; Kharkar, Prashant S.; Shah, Chetan P.; Rathod, Shrimant V. Synthesis, molecular docking and biological evaluation of novel 2-(3-chlorophenyl)quinoline-4-carboxamide derivatives as potent anti-breast cancer and antibacterial agents. Thai J. Pharm. Sci. 2021, 45(1), 41-49. [Indexed in Scopus].
JAN 2021
|
|
4
|
International Journal
Shah, Hriday; Jain, Ashvi S.; Joshi, Shreerang V.; Kharkar, Prashant S.* Crocetin and related oxygen diffusion-enhancing compounds: Review of chemical synthesis, pharmacology, clinical development and novel therapeutic applications. Drug Develop. Res. 2021 (In Press). [Clarivate Analytics Impact Factor (2019): 1.902].
FEB 2021
|
|
5
|
National Journal
Kharkar, Prashant S.; Shah, Chetan P.; Sahu, Niteshkumar U. Drug repurposing for Breast Cancer: Preliminary medicinal chemistry investigations and future perspectives. J. Indian Chem. Soc. 2020, 97, 1245-1250 [Clarivate Analytics Impact Factor (2019): 0.150].
AUG 2020
|
|
6
|
International Journal
Kharkar, Prashant S.* Cancer Stem Cell (CSC) inhibitors in oncology - A promise for a better therapeutic outcome: State of the art and future perspectives. J. Med. Chem. 2020, 63(24), 15279-15307. [Clarivate Analytics Impact Factor (2019): 6.205].
DEC 2020
|
|
7
|
International Journal
Padhariya, Komal; Athavale, Maithili; Srivastava Sangeeta; Kharkar, Prashant S.* Substituted chloroacetamides as potential cancer stem cell (CSC) inhibitors: Synthesis and biological evaluation. Drug Develop. Res. 2020, 81, 356-365. (DOI: 10.1002/ddr.21628) [Clarivate Analytics Impact Factor (2018): 1.902].
APRIL 2020
|
|
8
|
International Journal
Padhariya, Komal; Athavale, Maithili; Srivastava Sangeeta; Kharkar, Prashant S.* A novel series of substituted 1,2,3-triazoles as potential cancer stem cell (CSC) inhibitors: Synthesis and biological evaluation. Drug Develop. Res. 2020 (In Press) [Clarivate Analytics Impact Factor (2019): 1.902]
AUG 2020
|
|
9
|
International Journal
Kharkar, Prashant S.; Soni, Govind; Rathod, Vaibhavi; Shetty, Saritha; Gupta, M. K.; Yadav, Khushwant S. An outlook on procedures of conjugating folate to (co)polymers and drugs for effective cancer targeting. Drug Develop. Res. 2020, 81(7), 823-836.[Clarivate Analytics Impact Factor (2019): 1.902]
JUN 2020
|
|
10
|
International Journal
Sahoo, S.; Kharkar, Prashant S.; Sahu, Niteshkumar U.; Brijesh, S. Anxiolytic activity of Psidium guajava leaves ethanolic extract in mice subjected to chronic restraint stress. Phytotherapy Res. 2020. Published online on October 9, 2020. (DOI: 10.1002/ptr.6900) [Clarivate Analytics Impact Factor (2019): 4.087].
OCT 2020
|
|
11
|
International Journal
Telange, Darshan R.; Sohail, Nazish K; Hemke, Atul T.; Kharkar, Prashant S.; Pethe, Anil M. Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: Evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin. Drug Deliv. Transl. Res. 2020 (Published online July 21, 2020) (DOI: 10.1007/s13346-020-00822-4) [Clarivate Analytics Impact Factor (2019): 2.664].
JULY 2020
|
|
12
|
International Journal
Kharkar, Prashant S. Computational approaches for the design of (mutant-)selective tyrosine kinase inhibitors: State-of-the-art and future prospects. Curr. Top. Med. Chem. 2020, 17, 1522-1533. (DOI: 10.2174/1568026620666200502005853) [Clarivate Analytics Impact Factor (2019): 3.218].
MAY 2020
|
|
13
|
Book Chapter: Sahu, Niteshkumar U.; Shah, Chetan P.; Machhar, Janvhi S.; Kharkar, Prashant S. Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multi-Drug Resistance Era! In: In Silico Drug Design; Roy, K., Ed.; 1st ed.; Academic Press, London: 2019; pp 399-426.
APRIL 2019
|
|
14
|
International Journal
Shah, Mayank, D.; Kharkar, Prashant S.; Sahu, Nitesh U.; Desai, Krutika, B. Potassium 2-methoxy-4-vinylphenolate: a novel hit exhibiting quorum-sensing inhibition in Pseudomonas aeruginosa via LasIR/RhlIR circuitry. RSC Adv. 2019, 9, 40228-40239. (DOI: 10.1039/C9RA06612H) [Clarivate Analytics Impact Factor (2018): 3.049].
DEC 2019
|
|
15
|
International Journal
Patel, Dhaval; Kharkar, Prashant S.; Gandhi, Neha S.; Kaur, Ekjot; Dutt Shilpi; Nandave, Mukesh. Novel analogs of sulfasalazine as system xc - antiporter inhibitors: Insights from the molecular modeling studies. Drug Dev Res. 2019, 80(6), 758-777. (DOI: 10.1002/ddr.21557) [Clarivate Analytics Impact Factor (2017): 2.646].
SEPT 2019
|
|
16
|
International Journal
Shah, Chetan P.; Purushothaman, Gayathri, Thiruvenkatam, Vijay; Kirubakaran, Sivapriya; Juvale, Kapil; Kharkar, Prashant S.* Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2. Bioorg. Chem. 2019, 87, 753-764. (DOI: 10.1016/j.bioorg.2019.04.001) [Clarivate Analytics Impact Factor (2017): 3.929].
JUN 2019
|
|
17
|
International Journal
Salunke, Nishant; Kharkar, Prashant S.; Pandita, Nancy. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction. Biomed. Chromatogr. 2019, 33(6), e4489. (DOI: 10.1002/bmc.4489) [Clarivate Analytics Impact Factor (2017): 1.688].
JUN 2019
|
|
18
|
International Journal
Mishra, Shweta; Kharkar, Prashant S.; Pethe, Anil M. Biomass and waste materials as potential sources of nanocrystalline cellulose: Comparative review of preparation methods (2016 - Till date). Carbohydr. Polym. 2019, 207, 418-427. (DOI: 10.1016/j.carbpol.2018.12.004) [Clarivate Analytics Impact Factor (2017): 5.185].
MAR 2019
|
|
19
|
International Journal
Silbermann, Katja; Shah, Chetan P.; Sahu, Niteshkumar U.; Juvale, Kapil; Stefan, Sven M.; Kharkar, Prashant S.*; Wiese, Michael. Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2. Eur. J. Med. Chem. 2019, 164, 193-213. (DOI: 10.1016/j.ejmech.2018.12.019) [Clarivate Analytics Impact Factor (2017): 4.816].
FEB 2019
|
|
20
|
International Journal
Sahu, Niteshkumar U.; Purushothaman, Gayathri; Thiruvenkatam, Vijay; Kharkar, Prashant S.* Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Drug Dev Res. 2019, 80(1), 125-132. (DOI: 10.1002/ddr.21467) [Clarivate Analytics Impact Factor (2017): 2.646].
FEB 2019
|
|
21
|
International Journal
Machhar, Janvhi S.; Mittal, Ansh; Agrawal, Surendra; Pethe, Anil M.; Kharkar, Prashant S.* Computational prediction of toxicity of small organic molecules: state-of-the-art. Physical Sciences Reviews 2019, 4(10). (DOI:10.1515/psr-2019-0009) [Clarivate Analytics Impact Factor (2017): 2.959].
OCT 2019
|
|
22
|
International Journal
Damani-Shah, Hetal; Saranath, Dhananjaya; Das, Soma; Kharkar, Prashant; Karande, Anjali. In-silico identification of small molecules targeting H-Ras and in-vitro cytotoxicity with caspase-mediated apoptosis in carcinoma cells. J. Cell. Biochem. 2019, 120(4), 5519-5530. (DOI: 10.1002/jcb.27836) [Clarivate Analytics Impact Factor (2017): 2.959].
APRIL 2019
|
|
23
|
International Journal
Shah, Chetan P.; Kharkar, Prashant S.* Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Eur. J. Med. Chem. 2018, 158, 286-301. (DOI: 10.1016/j.ejmech.2018.09.016) [Clarivate Analytics Impact Factor (2017): 4.816].
OCT 2018
|
|
24
|
International Journal
Shah, Chetan; Kharkar, Prashant S.* Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. J. Enzyme Inhibit. Med. Chem. 2018, 33, 972-977. (DOI: 10.1080/14756366.2018.1474211) [Clarivate Analytics Impact Factor (2016): 4.293].
DEC 2018
|
|
25
|
International Journal
Sahu, Nitesh U.; Singh, V.; Ferraris, D. M.; Rizzi, M.; Kharkar, Prashant S.* Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors. Bioorg. Med. Chem. Lett. 2018, 28, 1714-1718. (DOI: 10.1016/j.bmcl.2018.04.045) [Clarivate Analytics Impact Factor (2016): 2.454].
JUN 2018
|
|
26
|
International Journal
Hoonjan, M.; Sachdeva, G.; Chandra, S.; Kharkar, Prashant S.; Sahu, N.; Bhatt, Purvi. Investigation of HSA as a biocompatible coating material for arsenic trioxide nanoparticles. Nanoscale 2018, 10, 8031-8041. (DOI: 10.1039/c7nr09503a) [Clarivate Analytics Impact Factor (2016): 7.367].
MAY 2018
|
|
27
|
International Journal
Warrier, Sona; Kharkar, Prashant S.* A coumarin based chemosensor for selective determination of Cu (II) ions based on fluorescence quenching. J. Lumin. 2018, 199, 407-415. (DOI: 10.1016/j.jlumin.2018.03.073) [Clarivate Analytics Impact Factor (2016): 2.686].
JULY 2018
|
|
28
|
International Journal
Tambe, Amruta; Pandita, Nancy; Kharkar Prashant S.; Sahu, Niteshkumar U. Encapsulation of boswellic acid with ß- and hydroxypropyl-ß-cyclodextrin: Synthesis, characterization, in vitro drug release and molecular modelling studies. J. Mol. Struct. 2018, 1154, 504-510. (DOI: 10.1016/j.molstruc.2017.10.061) [Thomson Reuters Impact Factor (2016): 1.753]
FEB 2018
|
|
29
|
International Journal
Warrier, Sona; Kharkar, Prashant S.* Highly selective on-off fluorescence recognition of Fe3+ based on a coumarin derivative and its application in live-cell imaging. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2018, 188, 659-664. (DOI: 10.1016/j.saa.2017.07.068) [Thomson Reuters Impact Factor (2016): 2.536]
JAN 2018
|
|
30
|
International Journal
Acharya, Pratap; Bansal, Ranju; Kharkar, Prashant S. Hybrids of steroid and nitrogen mustard as antiproliferative agents: Synthesis, in vitro evaluation and in silico inverse screening. Arzneim. Forsch. 2018, 68, 100-103. (DOI: 10.1055/s-0043-118538) [Thomson Reuters Impact Factor (2016): 0.706].
FEB 2018
|
|
31
|
International Journal
Rhyman, L.; Tursun, M.; Abdallah, H. A.; Choong, Y. S.; Parlak, C.; Kharkar, P.; Ramasami, P. Theoretical investigation of the derivatives of favipiravir (T-705) as potential drugs for Ebola virus. Phys. Sci. Rev. 2018, 3(9), 20170198. (DOI: 10.1515/psr-2017-0198) [Indexed in Web of Science]
SEPT 2018
|
|
32
|
International Journal
Vaghela, Madhuri; Sahu, Niteshkumar; Kharkar, Prashant S.; Pandita, Nancy. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats. Chem. Biol. Interact. 2017, 278, 141-151 (DOI: 10.1016/j.cbi.2017.10.015) [Thomson Reuters Impact Factor (2016): 3.143]
DEC 2017
|
|
33
|
International Journal
Dutta, Shreelekha; Kharkar, Prashant S.; Sahu, Niteshkumar U.; Khanna, Aparna. Molecular docking prediction and in vitro studies elucidate anti-cancer activity of phytoestrogens. Life Sci. 2017, 185, 73-84. (DOI: 10.1016/j.lfs.2017.07.015) [Thomson Reuters Impact Factor (2016): 2.936]
SEPT 2017
|
|
34
|
International Journal
Kharkar, Prashant S.* Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015). Exp. Opin. Therap. Pat. 2017, 27(7), 753-761. (DOI: 10.1080/13543776.2017.1325465) [Thomson Reuters Impact Factor (2016): 3.012].
JULY 2017
|
|
35
|
International Journal
Kulkarni, Mahesh R.; Mane, Madhav S.; Ghosh, Usha; Sharma, Rajiv; Lad, Nitin, P.; Srivastava, Ankita; Kulkarni-Almeida, Asha; Kharkar, Prashant S.; Khedkar, Vijay, M.; Pandit, S. S. Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors. Eur. J. Med. Chem. 2017, 134, 366-378. (DOI: 10.1016/j.ejmech.2017.02.062) [Thomson Reuters Impact Factor (2016): 4.519].
JULY 2017
|
|
36
|
International Journal
Murahari, M.; Kharkar, Prashant S.; Lonikar, N.; Mayur, Y. C. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents. Eur. J. Med. Chem. 2017, 130, 154-170. (DOI: 10.1016/j.ejmech.2017.02.022) [Thomson Reuters Impact Factor (2016): 4.519].
APRIL 2017
|
|
37
|
International Journal
Gadekar, Pradip K.; Roychowdhury, Abhijit; Kharkar, Prashant S.; Khedkar, Vijay M.; Arkile, Manisha; Manek, Hardik; Sarkar, Dhiman; Sharma, Rajiv; Vijayakumar, V.; Sarveswari, S. Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents. Eur. J. Med. Chem. 2016, 122, 475-487. (DOI: 10.1016/j.ejmech.2016.07.001) [Thomson Reuters Impact Factor (2015): 3.902].
OCT 2016
|
|
38
|
International Journal
Kharkar, Prashant S.*; Ramasami, Ponnadurai; Choong, Yee Siew; Rhyman, Lydia; Warrier, Sona. Discovery of anti-Ebola drugs: A computational drug repositioning case study. RSC Adv. 2016, 6, 26329–26340 (DOI: 10.1039/C6RA01704E) [Thomson Reuters Impact Factor (2014): 3.84].
MAR 2016
|
|
39
|
National Journal
Gala, Viraj C.; John, Nithya R.; Bhagwat, Ashok M.; Datar, Ajit G.; Kharkar, Prashant S.; Desai, Krutika B. Attenuation of quorum sensing-regulated behaviours by Tinospora cordifolia extract and identification of its active constituents. Ind. J. Med. Res. 2016, 144, 92-103. (DOI: 10.4103/0971-5916.193295) [Thomson Reuters Impact Factor (2015): 1.446]
JULY 2016
|
|
40
|
International Journal
Sahu, Niteshkumar U.; Kharkar Prashant S.* Computational drug repositioning: A lateral approach to traditional drug discovery? Curr. Top. Med. Chem. 2016, 16(19), 2069-2077. (DOI: 10.2174/1568026616666160216153249) [Thomson Reuters Impact Factor (2014): 3.402]
AUG 2016
|
|
41
|
International Conference
Book Chapter: Warrier, Sona; Kharkar, Prashant S. Inverse Virtual Screening in Drug Repositioning: Detailed Investigation and Case Studies. In: Proceedings of International Conference on Pure and Applied Chemistry (ICPAC)-2014, Mauritius, Ramasami, P., Ed., Springer 2016
OCT 2016
|
|
42
|
International Conference
Bhandare, Richie B.; Gao, R.; Canney, D. J.; Kharkar, Prashant S. Novel ?-Butyrolactone Derivatives as Muscarinic Receptor Antagonists: Pharmacophore Elucidation and Docking Analyses. In: Proceedings of International Conference on Pure and Applied Chemistry (ICPAC)-2014, Mauritius, Ramasami, P., Ed., Springer 2016
OCT 2016
|
|
43
|
International Journal
Chhabria, Sagar V.; Akbarsha, Mohammad A.; Li, Albert P.; Kharkar, Prashant S., Desai, Krutika B. In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic remodeling, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression. Apoptosis 2015, 20(10), 1388-1409. (DOI: 10.1007/s10495-015-1159-4) [Thomson Reuters Impact Factor (2013): 3.614].
OCT 2015
|
|
44
|
International Journal
Shah, Chetan P.; Kharkar, Prashant S.* Inosine 5’-monophosphate dehydrogenase (IMPDH) inhibitors as antimicrobial agents: Recent progress and future perspectives. Fut. Med. Chem. 2015, 7(11), 1415-1429. (DOI: 10.4155/fmc.15.72) [Thomson Reuters Impact Factor (2013): 4.000].
NOV 2015
|
|
45
|
International Journal
Patel, Dhaval; Kharkar, Prashant S.; Nandave, Mukesh. Emerging roles of system Xc- antiporter and its inhibition in CNS disorders. Mol. Membr. Biol. 2015, 32(4), 89-116. (DOI: 10.3109/09687688.2015.1096972) [Thomson Reuters Impact Factor (2013): 1.729].
APRIL 2015
|
|
46
|
International Journal
Singasane, Namrata; Kharkar, Prashant S.; Ceruso, Mariangela; Supuran, Claudiu T.; Toraskar, Mrunmayee P. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties. J. Enz. Inhibit. Med. Chem. 2015, 30(6), 901-907. (DOI: 10.1021/ml500140t) [Thomson Reuters Impact Factor (2013): 2.383].
JUN 2015
|
|
47
|
International Journal
Kharkar, Prashant S.*; Borhade, Sheetal; Dangi, Arti; Warrier, Sona. In search of novel anti-inflammatory agents: Computational repositioning of approved drugs. J. Comput. Sci. 2015, 10, 215-224. (DOI: 10.1016/j.jocs.2015.01.002) [Thomson Reuters Impact Factor (2013): 1.512].
SEPT 2015
|
|
48
|
International Journal
Preeja, M. P.; Palivela, Hemant; Soman, K. P.; Kharkar, Prashant S. Ligand-based virtual screening using random walk kernel and empirical filters. Procedia Comput. Sci. 2015, 57, 418-427. (DOI: 10.1016/j.procs.2015.07.508) [Thomson Reuters Impact Factor (2012): None].
JUN 2015
|
|
49
|
International Journal
Warrier, Sona; Kharkar, Prashant S.* Fluorescent probes for biomedical applications- A patent review (2009-2014). Pharm. Patent Analyst 2014, 3(5), 543-560. (DOI: 10.4155/ppa.14.41) [Thomson Reuters Impact Factor (2012): None].
SEPT 2014
|
|
50
|
International Journal
Modi, Gyan; Sharma, Horrick; Kharkar, Prashant S.; Dutta, Aloke K. Understanding the structural requirements of hybrid (S)-6-((2-(4-phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydro-naphthalen-1-ol and its analogs as D2/D3 receptor ligands: A three-dimensional quantitative structure-activity relationship (3D QSAR) investigation. Med. Chem. Comm. 2014, 5(9), 1384-1392. (DOI: 10.1039/C4MD00159A) [Thomson Reuters Impact Factor (2012): 2.722].
SEPT 2014
|
|
51
|
International Journal
Pichake, Jayashree.; Kharkar, Prashant S.; Ceruso, Mariangela; Supuran, Claudiu T.; Toraskar, Mrunmayee P. Carbonic anhydrase inhibitors: Design, synthesis and biological evaluation of novel sulfonyl semicarbazide derivatives. ACS Med. Chem. Lett. 2014, 5(7), 793-796. (DOI: 10.1021/ml500140t) [Thomson Reuters Impact Factor (2012): 3.311].
JULY 2014
|
|
52
|
International Journal
Kharkar, Prashant S.* Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets. F1000Research 2014, 3, 40. (DOI: 10.12688/f1000research.3-40.v2) [Thomson Reuters Impact Factor (2012): None].
MAR 2014
|
|
53
|
International Journal
Kharkar, Prashant S.*; Warrier, Sona; Gaud, R. S. Reverse docking: A powerful tool for drug repositioning and drug rescue. Fut. Med. Chem. 2014, 6(3), 333-342. (DOI: 10.4155/fmc.13.207) [Thomson Reuters Impact Factor (2012): 3.310].
MAR 2014
|
|
54
|
International Journal
Dunkern, T.; Chavan, S.; Bankar, D.; Patil, A.; Kulkarni, P.; Kharkar, Prashant S.; Prabhu, A.; Goeble, H.; Rolser, E.; Burckhardt-Boer, W.; Arumugam, P.; Makhija, M. T. Design, synthesis and biological evaluation of novel inosine monophosphate dehydrogenase inhibitors. J. Enz. Inhib. Med. Chem. 2014, 29(3), 408-419. (DOI: 10.3109/14756366.2013.793184) [Thomson Reuters Impact Factor (2012): 1.495].
MAR 2014
|
|
55
|
International Journal
Ramdhave, Anup S.; Patel, Dhaval; Ramya, I.; Nandave, Mukesh; Kharkar, Prashant S. Targeting heat shock protein 90 for malaria. Mini Rev. Med. Chem. 2013, 13(13), 1903-1920. (DOI: 10.2174/13895575113136660094) [Thomson Reuters Impact Factor (2012): 2.865].
NOV 2013
|
|
56
|
International Journal
Agrawal, Madhavi; Kharkar, Prashant; Moghe, Sonali; Mahajan, Tushar; Deka, Vaishali; Thakkar, Chandani; Nair, Amruta; Mehta, Chirag; Bose, Julie; Kulkarni-Almeida, Asha; Bhedi, Dilip; Vishwakarma, Ram A. Discovery of thiazolyl-phthalazinone acetamides as potent glucose uptake activators via high-throughput screening. Bioorg. Med. Chem. Lett. 2013, 23(20), 5740-5743. (DOI: 10.1016/j.bmcl.2013.07.067) [Thomson Reuters Impact Factor (2011): 2.554].
OCT 2013
|
|
57
|
International Journal
Gopishetty, B. Zhang, S.; Kharkar, Prashant S.; Antonio, T.; Reith, M.; Dutta, Aloke K. Modification of agonist binding moiety in hybrid derivative 5/ 7-{[2-(4-Aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/ -2-amino versions: Impact on functional activity and selectivity for dopamine D2/D3 receptors. Bioorg. Med. Chem. 2013, 21, 3164-3174. (DOI: 10.1016/j.bmc.2013.03.059) [Thomson Reuters Impact Factor (2011): 2.921].
JUN 2013
|
|
58
|
Book Chapter: Kharkar, Prashant S. In Silico Absorption, Distribution, Metabolism and Excretion. In: In Silico Drug Discovery and Delivery, Markus, L., Ed., Future Science Group, 2013, pp 149-162
AUG 2013
|
|
59
|
International Journal
Dunkern, T.; Prabhu, A.; Kharkar, Prashant S.; Goeble, H.; Rolser, E.; Burckhardt-Boer, W.; Arumugam, P.; Makhija, M. T. Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5’-monophosphate dehydrogenase II (IMPDH II) inhibitors. J. Comput. Aided Mol. Des. 2012, 26, 1277-1292. (DOI: 10.1007/s10822-012-9615-5) [Thomson Reuters Impact Factor (2012): 3.84].
NOV 2012
|
|
60
|
International Journal
Ghosh, B.; Antonio, T.; Zhen, J.; Kharkar, P.; Reith, M. E.; Dutta, A. K. Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo-[d]thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models. J. Med. Chem. 2010, 53, 1023-1037. (DOI: 10.1021/jm901184n) [Thomson Reuters Impact Factor (2008): 4.898].
FEB 2010
|
|
61
|
International Journal
Kharkar, Prashant S.* Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery. Curr. Top. Med. Chem. 2010, 10, 116-121. (Invited review) (DOI: 10.2174/156802610790232224) [Thomson Reuters Impact Factor (2008): 4.268].
JAN 2010
|
|
62
|
International Journal
Kharkar, Prashant, S.; Deodhar, Meenakshi N.; Kulkarni, Vithal M. Design, synthesis, anti-fungal activity, and ADME prediction of functional analogues of terbinafine. Med. Chem. Res. 2009, 18, 421-432. (DOI: 10.1007/s00044-008-9138-8) [Thomson Reuters Impact Factor (2008): 0.731].
JULY 2009
|
|
63
|
International Journal
Kharkar, Prashant S.; Batman, Angela M; Zhen, J.; Beardsley, Patrick M.; Reith, Maarten E. A.; Dutta, Aloke K. Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryl-oxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereo-isomers for activity toward monoamine transporters. ChemMedChem 2009, 4, 1075-1085. (DOI: 10.1002/cmdc.200900085) [Thomson Reuters Impact Factor (2008): 3.15].
JULY 2009
|
|
64
|
International Journal
Kharkar, Prashant S.; Dutta, Aloke K. Metal –protein attenuating compounds (MPACs): An emerging approach for the treatment of neurodegenerative disorders. Curr. Bioactive Compounds 2008, 4, 57-67. (Invited review) (DOI: 10.2174/157340708785294226) [Thomson Reuters Impact Factor (2007): None].
APRIL 2008
|
|
65
|
International Journal
Kharkar, Prashant S.; Reith, Maarten E. A.; Dutta, Aloke K. Three-dimensional quantitative structure-activity relationship (3D QSAR) and pharmacophore elucidation of tetrahydropyran derivatives as serotonin and norepinephrine transporter inhibitors. J. Comput.-Aided Mol. Des., 2008, 22, 1-17. (DOI: 10.1007/s10822-007-9146-7) [Thomson Reuters Impact Factor (2016): 3.028].
JAN 2008
|
|
66
|
International Journal
Brown, Dennis A.; Kharkar, Prashant; Parrington, Ingrid; Reith, Maarten; Dutta, Aloke K. Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]-quinolines moieties for dopamine D2 and D3 receptors: Binding characterization at D2/D3 receptors and elucidation of a pharmacophore model. J. Med. Chem. 2008, 51, 7806-7819. (DOI: 10.1021/jm8008629) [Thomson Reuters Impact Factor (2016): 6.259].
DEC 2008
|
|
67
|
International Journal
Schmitt, K. C.; Zhen, J.; Kharkar, P.; Mishra, M.; Chen, N.; Dutta, A. K.; Reith, M. E. A. Interaction of cocaine, benztropine-, and GBR12909-like compounds with wildtype and mutant human dopamine transporters: molecular features that differentially determine antagonist binding properties. J. Neurochem. 2008, 107, 928-940. (DOI: 10.1111/j.1471-4159.2008.05667.x) [Thomson Reuters Impact Factor (2016): 4.083].
NOV 2008
|
|
68
|
Book Chapter: Kharkar, Prashant S., Reith, Maarten, E. A., Dutta, Aloke, K. Structure-Activity Relationship Study of Piperidine Derivatives for Dopamine Transporters In: Dopamine Transporters: Chemistry, Biology, and Pharmacology, Trudell, M., Izenwasser, S., Eds., Wiley, John & Sons, Incorporated 2008, pp. 233-264
JULY 2008
|
|
69
|
International Journal
Kharkar, Prashant S.; Kulkarni, V. M. A Proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug design. Org. Biomol.Chem. 2003, 1, 1315– 1322. (DOI: 10.1039/b212211a) [Thomson Reuters Impact Factor (2016): 3.564].
APRIL 2003
|
|
70
|
National Journal
Karki, R. G.; Gokhale, V. M.; Kharkar, P. S.; Kulkarni, V. M. Azole compounds designed by molecular modeling show antifungal activity as predicted. Ind. J. Chem. 2003, 42B, 372-381 [Thomson Reuters Impact Factor (2016): 0.353].
FEB 2003
|
|
71
|
International Journal
Kharkar, Prashant S.; Desai, B.; Varu, B.; Loriya, R.; Gaveria, H.; Naliapara, Y.; Shah, A.; Kulkarni, V. M. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents. J. Med. Chem. 2002, 45, 4858-4867. (DOI: 10.1021/jm020217z) [Thomson Reuters Impact Factor (2016): 6.259].
OCT 2002
|
|